Sabina Chiaretti | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia-positive acute lymphoblastic leukaemia	HEMATOLOGICAL ONCOLOGY	2021
Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996	AMERICAN JOURNAL OF HEMATOLOGY	2021
Dasatinib-Blinatumomab for Ph-Positive ALL. Reply	NEW ENGLAND JOURNAL OF MEDICINE	2021
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trial	AMERICAN JOURNAL OF HEMATOLOGY	2021
Ponatinib for the treatment of Ph-like acute lymphoblastic leukemia	LEUKEMIA & LYMPHOMA	2021
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY	MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES	2021
Host immune system modulation in Ph+ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab	BLOOD	2021
Efficacy of imatinib and chemotherapy in a pediatric patient with Philadelphia-like acute lymphoblastic leukemia with Ebf1-Pdgfrb fusion transcript	LEUKEMIA & LYMPHOMA	2020
Ph+ Acute Lymphoblastic Leukaemia in Italy During the Covid-19 Pandemic. A Campus ALL Study	BRITISH JOURNAL OF HAEMATOLOGY	2020
Practical guidance for the management of acute lymphoblastic leukemia in the adolescent and young adult population	THERAPEUTIC ADVANCES IN HEMATOLOGY	2020
Design of a comprehensive fluorescence in situ hybridization assay for genetic classification of T-cell acute lymphoblastic leukemia	THE JOURNAL OF MOLECULAR DIAGNOSTICS	2020
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimale residual disease-oriented GIMEMA LAL1913	HAEMATOLOGICA	2020
A review of current induction strategies and emerging prognostic factors in the management of children and adolescents with acute lymphoblastic leukemia	EXPERT REVIEW OF HEMATOLOGY	2020
Dasatinib-blinatumomab for ph-positive acute lymphoblastic leukemia in adults	NEW ENGLAND JOURNAL OF MEDICINE	2020
National Italian Delphi panel consensus: Which measures are indicated to minimize pegylated-asparaginase associated toxicity during treatment of adult acute lymphoblastic leukemia?	BMC CANCER	2020
Is Less More? Intensive Versus Non-Intensive Approach to Adults with Ph+ ALL	CLINICAL LYMPHOMA MYELOMA & LEUKEMIA	2020
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study	AMERICAN JOURNAL OF HEMATOLOGY	2020
Atypical chronic myeloid leukemia in a patient with aplastic anemia	ACTA HAEMATOLOGICA	2019
BCR/ABL1–like acute lymphoblastic leukemia: How to diagnose and treat?	CANCER	2019
Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia	LEUKEMIA & LYMPHOMA	2019

Progetti di Ricerca

Dissecting and redefining the interplay between minimal residual disease and genetic features of Ph-like ALL:
The BCR/ABL1-like acute lymphoblastic leukemia (ALL) predictor: refinement of clinical and biological features of BCR/ABL1-like ALL patients, and validation and reproducibility of the diagnostic method